Literature DB >> 9241814

Clinical trials of malaria vaccines: progress and prospects.

C A Facer1, M Tanner.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9241814     DOI: 10.1016/s0065-308x(08)60044-5

Source DB:  PubMed          Journal:  Adv Parasitol        ISSN: 0065-308X            Impact factor:   3.870


× No keyword cloud information.
  6 in total

1.  Use of reconstituted influenza virus virosomes as an immunopotentiating delivery system for a peptide-based vaccine.

Authors:  F Pöltl-Frank; R Zurbriggen; A Helg; F Stuart; J Robinson; R Glück; G Pluschke
Journal:  Clin Exp Immunol       Date:  1999-09       Impact factor: 4.330

2.  Long-lasting protective immune response to the 19-kilodalton carboxy-terminal fragment of Plasmodium yoelii merozoite surface protein 1 in mice.

Authors:  Pimmada Jeamwattanalert; Yuvadee Mahakunkijcharoen; Leera Kittigul; Pakpimol Mahannop; Sathit Pichyangkul; Chakrit Hirunpetcharat
Journal:  Clin Vaccine Immunol       Date:  2007-02-21

3.  Vaccination with novel immunostimulatory adjuvants against blood-stage malaria in mice.

Authors:  Zhong Su; Mi-Fong Tam; Dragana Jankovic; Mary M Stevenson
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

4.  Rhop-3 protein conservation among Plasmodium species and induced protection against lethal P. yoelii and P. berghei challenge.

Authors:  Tongmin Wang; Hisashi Fujioka; Judith A Drazba; Tobili Y Sam-Yellowe
Journal:  Parasitol Res       Date:  2006-03-16       Impact factor: 2.289

5.  Therapy with a combination of low doses of interleukin 12 and chloroquine completely cures blood-stage malaria, prevents severe anemia, and induces immunity to reinfection.

Authors:  K Mohan; H Sam; M M Stevenson
Journal:  Infect Immun       Date:  1999-02       Impact factor: 3.441

6.  Ficolin-A Enhances Inhibition of the C-Terminal 19 kDa Region of Merozoite Surface Protein-1 of Plasmodium berghei Using Test In Vivo.

Authors:  F Chen; Q Liu; Y Xue; Yh Huang; Fy Huang; Y Lin; Gh Tan; J Zhou
Journal:  Iran J Parasitol       Date:  2013-01       Impact factor: 1.012

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.